Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.

Similar Items

• ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
  by: Noseworthy, J, et al.
  Published: (1989)
• The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
  by: Noseworthy, J
  Published: (1991)
• Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
  by: Noseworthy, J, et al.
  Published: (1990)
• The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.
  by: Noseworthy, J, et al.
  Published: (1994)
• The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]
  by: Noseworthy, J, et al.
  Published: (2001)